Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Truelin Pharmaceutical Technology Development, also known as Shandong Chulin Pharmaceutical, is a biotechnology company headquartered in Jinan, China, that focuses on the research and development of innovative small molecule therapeutics. Founded in 2016, the company provides comprehensive pharmaceutical technology services, including medicinal chemistry, lead optimization, and process development for active pharmaceutical ingredients (APIs). Truelin operates as both an independent R&D entity and a strategic partner for pharmaceutical companies, leveraging its expertise in chemical synthesis to advance drug candidates from discovery through pre-clinical stages. The firm is dedicated to improving drug efficacy and safety through advanced molecular design and technology transfer services.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong Truelin Pharmaceutical Technology Development.